Seppo Auriola
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Biological Psychiatry top 2%
Papers in
-
- Metabolomics and Mass Spectrometry Studies 14
- Oncology 54
- Drug Transport and Resistance Mechanisms 28
- Bone health and treatments 21
- Co-authors
- Jukka Mönkkönen (25 shared papers)Arto Urtti (30 shared papers)Michael J. Rogers (9 shared papers)Julie C. Frith (7 shared papers)Marko Lehtonen (30 shared papers)Kati Hanhineva (25 shared papers)Jouko Vepsäläinen (17 shared papers)Hannu Mönkkönen (12 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (13 papers)Journal of Chromatography A (11 papers)European Journal of Pharmaceutical Sciences (8 papers)Scientific Reports (7 papers)Molecular Pharmaceutics (7 papers)
- Partner nations
- FinlandGermanyUnited Kingdom
In The Last Decade
Seppo Auriola
251 papers receiving 8.8k citations
Peers
Comparison fields: 5 of 156
- Pharmaceutical Science 432
- Biological Psychiatry 154
- Oncology 1.6k
- Pharmacology 512
- Biochemistry 424
Countries citing papers authored by Seppo Auriola
This map shows the geographic impact of Seppo Auriola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seppo Auriola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seppo Auriola more than expected).
Fields of papers citing papers by Seppo Auriola
This network shows the impact of papers produced by Seppo Auriola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seppo Auriola. The network helps show where Seppo Auriola may publish in the future.
Co-authors
The 25 scholars most cited alongside Seppo Auriola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 252 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 282 | |
| 2 | 2003 | 272 | |
| 3 | 2006 | 249 | |
| 4 | 2001 | 227 | |
| 5 | Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. | 1997 | 226 |
| 6 | 1999 | 223 | |
| 7 | 2009 | 218 | |
| 8 | 2018 | 196 | |
| 9 | 1999 | 189 | |
| 10 | 2005 | 181 | |
| 11 | 2002 | 157 | |
| 12 | 1998 | 154 | |
| 13 | 2020 | 147 | |
| 14 | 2007 | 137 | |
| 15 | 2011 | 133 | |
| 16 | 2006 | 113 | |
| 17 | 2019 | 107 | |
| 18 | 2005 | 107 | |
| 19 | 2005 | 105 | |
| 20 | 2011 | 104 |
About Seppo Auriola
Seppo Auriola is a scholar working on Molecular Biology, Oncology, Spectroscopy, Biochemistry and Plant Science, having authored 252 papers that have together received 9.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (28 papers), Analytical Chemistry and Chromatography (24 papers), Mass Spectrometry Techniques and Applications (22 papers), Bone health and treatments (21 papers), Amino Acid Enzymes and Metabolism (19 papers), Pharmacogenetics and Drug Metabolism (15 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Advanced Drug Delivery Systems (12 papers). The work is most often cited by research in Pharmaceutical Science (432 citations), Biological Psychiatry (154 citations), Oncology (1.6k citations), Pharmacology (512 citations) and Biochemistry (424 citations). Seppo Auriola has collaborated with scholars based in Finland, Germany and United Kingdom. Frequent co-authors include Jukka Mönkkönen, Arto Urtti, Michael J. Rogers, Julie C. Frith, Marko Lehtonen, Kati Hanhineva, Jouko Vepsäläinen, Hannu Mönkkönen, Markku Pasanen and Risto Kostiainen. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Journal of Chromatography A, European Journal of Pharmaceutical Sciences, Scientific Reports and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.